Belmont, MA, United States of America

Ghaleb Daouk

This inventor holds 2 USPTO granted patents, plus 1 CIPO patent. Top assignees: Avicena Group, Inc., The General Hospital Corporation, Other. Active years: 2004-2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ghaleb Daouk. Retrieved from https://idiyas.com/inventor/ghaleb-daouk

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 50.0


Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 2004-2007

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Ghaleb Daouk: Innovator in Neurological Treatments

Introduction

Ghaleb Daouk is a notable inventor based in Belmont, MA (US). He has made significant contributions to the field of neurological treatments through his innovative use of creatine compounds. With a total of 2 patents, his work focuses on addressing various diseases of the nervous system.

Latest Patents

Ghaleb Daouk's latest patents revolve around the use of creatine or creatine analogs for the treatment of diseases of the nervous system. His inventions detail the therapeutic effectiveness of creatine compounds, including creatine, creatine phosphate, and analogs such as cyclocreatine. These compounds are proposed as effective agents against a range of neurological disorders, including diabetic and toxic neuropathies, Alzheimer's disease, Parkinson's disease, and multiple sclerosis, among others. The patents describe various methods of utilizing these compounds, including their roles as substrates for creatine kinase and as inhibitors of this enzyme.

Career Highlights

Throughout his career, Ghaleb Daouk has worked with notable organizations, including Avicena Group, Inc. His experience in the field has allowed him to develop innovative solutions for complex neurological issues.

Collaborations

Ghaleb has collaborated with esteemed colleagues such as M Flint Beal and Rima Kaddurah-Daouk. These partnerships have contributed to the advancement of his research and the development of his patents.

Conclusion

Ghaleb Daouk's contributions to the field of neurological treatments through his innovative use of creatine compounds highlight his role as a significant inventor. His work continues to pave the way for new therapeutic approaches to complex diseases of the nervous system.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…